Rxo (RXO) Change in Account Payables (2021 - 2026)

Rxo (RXO) has reported Change in Account Payables for 6 consecutive years, with $49.0 million the latest figure, recorded in Q1 2026.

• Change in Account Payables for Q1 2026 came in at $49.0 million, up 187.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $89.0 million (up 211.25% YoY), and the FY2025 annual result was -$16.0 million, up 75.38% from the prior year.
• Change in Account Payables was $49.0 million for Q1 2026 at Rxo, down from $58.0 million in the prior quarter.
• Over five years, Change in Account Payables peaked at $216.0 million in Q1 2022 and troughed at -$121.0 million in Q2 2022.
• Average Change in Account Payables over 5 years is -$7.8 million, with a median of -$20.0 million recorded in 2024.
• The widest YoY moves for Change in Account Payables: up 422.22% in 2025, down 364.29% in 2025.
• Over 5 years, Change in Account Payables stood at -$39.0 million in 2022, then increased by 23.08% to -$30.0 million in 2023, then jumped by 40.0% to -$18.0 million in 2024, then jumped by 422.22% to $58.0 million in 2025, then dropped by 15.52% to $49.0 million in 2026.
• Per Business Quant data, the three most recent Change in Account Payables figures were $49.0 million in Q1 2026, $58.0 million in Q4 2025, and $19.0 million in Q3 2025.